The profile of patients with obstructive uropathy in Cameroon: case of the Douala General Hospital by Halle, Marie Patrice et al.




The profile of patients with obstructive uropathy in Cameroon: case of the Douala 
General Hospital 
 
Marie Patrice Halle1,2,&, Linda Njonkam Toukep2, Samuel Ekane Nzuobontane2,3, Hermine Fouda Ebana2,4, Gregory Halle Ekane2,3, 
Eugene Belley Priso2,4 
 
1Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon, 2Douala General Hospital, Douala, Cameroon, 3Faculty 
of Health Sciences, University of Buea, Buea, Cameroon, 4Faculty of Medicine and Biomedical Sciences, University of Yaoundé , Yaoundé, 
Cameroon 
 
&Corresponding author: Marie Patrice Halle, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Cameroon       
 
Key words: Profile, outcome, obstructive uropathy, Douala general hospital, Cameroon 
 
Received: 10/10/2015 - Accepted: 01/02/2016 - Published: 03/03/2016 
 
Abstract  
Introduction: Obstructive uropathy can lead to irreversible kidney damage. The etiology largely determined by the patient's age can be benign or 
malignant. This study aimed at determining the profile and outcome of patients with obstructive uropathy in Cameroon. Methods: A cross 
sectional study carried out in the urology unit of the Douala General Hospital, including patients with a diagnosis of obstructive uropathy seen from 
January 2004 to December 2013. Clinical profile, treatment and outcome data were obtained from patients records. Results: Of the 229 patients 
included 69% were men, mean age 50 ±18 years. Associated comorbidities were hypertension, diabetes, and HIV. Mean haemoglobin 
8,40±2,4g/dl, mean GFR 10,3 ±10ml/min, 94 (41%) patients needed emergency dialysis. Symptoms at presentation: asthenia (57%), anorexia 
(55%), loin pain (37%), vomiting (28%), oedema (20%), and anuria (15%). Urinary tract infection was present in 33 patients. Main aetiologies of 
obstruction: urolithiasis (35%), begnin prostatic hypertrophy (27%), prostatic cancer (12%), cervical cancer (16%), and congenital malformations 
(5%). Drainage was effective in 102 (45%) patients, 63 (28%) recovered completely, 91 (41%) were loss to follow up, 49 (22%) died and more 
women (p=0.02). Mortality was associated with prostatic cancer (p=0.000), cervical cancer (p=0.004) and radiotherapy (p=0.03). 
Conclusion: Patients with obstructive uropathy presented with significant impaired renal function. Main causes were urinary stones, prostatic 
hypertrophy, prostatic and cervical cancers. Renal recovery was poor, loss to follow up and mortality high. Specific strategies to target 
improvement in renal recovery and patient's survival are needed in this patient's group. 
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Obstructive nephropathy, a relatively common condition for 
practicing urologists refers to the mechanical or functional changes 
in the urinary tract that interfere with normal urinary flow. [1]. It 
may be acute or chronic, complete or incomplete, unilateral or 
bilateral and can lead to rapid deterioration in renal function and 
irreversible kidney damageif urinary drainage is not rapidly 
corrected [2,3]. Obstruction is a relatively common cause of 
community-acquired akut kidney injury [4,5]. In a study carried out 
in Sudan 40% of participants with obstructive uropathy presented 
with significant renal impairment and 23% needed emergency 
dialysis [6]. The etiologies are diverse, can be benign or malignant, 
largely determined by the age of the patient. In children the main 
aetiologies are uretero-pelvic junction obstruction and congenital 
urethral valves and meatal stenosis [6-8]. In young adults, calculi 
are primary cause while in older patients benign prostatic 
hyperplasia, calculi and malignancy are the common causes [1,6]. 
Hydro nephrosis is a usual situation in the course of advanced 
malignancies(cervical, bladder, prostate, or colorectal cancer)in 
adults and the cause of obstruction may be invasive-infiltration of 
the ureters by tumor extrinsic compression by a retroperitoneal 
primary or metastatic neoplasia, and this may be aggravated by 
periureteral fibrosis, secondary to previous chemotherapy and 
radiation therapy [9, 10]. The signs of obstructive nephropathy are 
often nonspecific and variable depending on the time interval over 
which the obstruction occurred, the lateralization and the severity of 
obstruction. The pattern of clinical presentation can be loin pain, 
lower urinary tract symptoms, fever, mass effect, urine retention, 
and anuria, impaired renal function with uremic signs [6, 8, 11]. 
Regardless of the patient´s age, appropriate diagnosis and prompt 
surgical or interven¬tional drainageis necessary to avoid irreversible 
renal damage [12]. It is often-reversible and the degree of renal 
recovery depends primarily on the extent and duration of the 
obstruction together with the presence or absence of other 
comorbidity [13]. In a study on patients with obstructive uropathy in 
Sudan renal function recovery was 100% in patients with acute 
obstruction and was stabilized in 90% of patients with chronic 
obstruction and 4 patients had end-stage renal failure [6]. In case 
of malignancy, the prognosis is often poor and studies have shown 
that malignancy is a factor of increase morbidity and mortality [14]. 
Most publications on the topic have focused on individual causes of 
obstruction or obstruction in specific populations. Few data on the 
general profile and outcome of patients with obstructive uropathy 
exist in Sub-Saharan Africa (SSA).We therefore in this study 
determined the patterns of presentation, the causes, management 
and outcome of patients with obstructive uropathy in a tertiary 
referral hospital in Cameroon, with the aim to improve the 





Study setting: this was a cross sectional study carried out in the 
urology unit of the Douala General Hospital (DGH) in Cameroon a 
tertiary public hospital and one of the main reference hospital in the 
country.. It has the unique public haemodialysis centre of the littoral 
region (approximately 3millions inhabitants) and the largest of the 
country and serves as the referral hospital for most patients with 
kidney and urologic diseases in the region. Ethical approval was 
obtained from the Douala University Ethical review board, and 
administrative authorization from the DGH. 
  
Patients and methods: Medical files of patients with a confirmed 
diagnosis of obstructive uropathy seen in the urologic units from 
January 1, 2004 to December 31, 2013 irrespective from age were 
included. For all patients the following data were collected by a final 
year's undergraduate medical student: socio-demographic including 
age (in years), sex. Clinical data such as major comorbidities 
(hypertension, diabetes, HIV, gout,) signs and aetiology of 
obstruction, urine output, biological variables (haemoglobin, urea 
and creatinine, urine dipstick and culture), therapeutic aspect and 
outcome were recorded. The diagnosis of obstructive uropathy was 
based on unilateral or bilateral ureteropelvic dilatation confirmed by 
ultrasonography and/or computerized tomography. Kidney failure 
was all patients with elevated serum creatinine and estimated 
glomerular filtration rate (eGFR) <60ml: min/ 1.73m2 on admission. 
  
Statistical analysis : Data were analysed using the software 
STATA, version 11.1 Results were presented as count and 
percentages, mean and standard deviation (SD).The comparison of 
the qualitative variables was made with the Chi-squared test and 
the quantitative variables with the student testand the Kolmogorov-
Smirnov test was used for dichotomic variables. P-values of < 0.05 
were considered signifi¬cant. Logistic regression was used to 





Two third of the 229 patients included were men. Mean age was 50 
±18 years. Associated comorbidities were hypertension, diabetes, 
HIV and gout. Main symptoms at presentation were asthenia (57%), 
anorexia (55%), loin pain (37%), vomiting (28%), oedema (20%), 
dyspnoea (10%), oliguria (33%), anuria (15%), and macroscopic 
haematuria (7%). Urinary tract infection was present in 33 (15%) 
patients (Table 1). Mean haemoglobin was 8,40 ± 2,4g/dl and 
mean GFR 10,3 ± 10ml/min/ 1.73m2.Renal function impairment 
occur in 172 (76%) patients, with 94 (41%) of emergency dialysis 
need (Table 1). Main aetiologies of obstruction were urolithiasis 
(35%), begnin prostatic hypertrophy (27%), prostatic cancer 
(12%), cervical cancer (16%), congenital urethral valves and pelvi 
ureteral junction obstruction (5%), (Table 2). Drainage was done in 
102 (45%) patients, mainly bladder catheterization (19.6%) 
(p=0.005) and double JJ insertion (19%), Adjuvants treatment were 
analgesics, chemotherapy, radiotherapy more in women (p=0.007), 
hormonal therapy (p= 0.03), and Alfa-blocker (p= 0.001) more 
used in men (Table 3). Complete renal recovery occurred in 63 
(28%) of patients, 94 (41%) were lost to follow up and 49 (22%) 
patients died and this was higher amongst women (p=0.02). 
Prostatic cancer (p=0.000), cervical cancer (0.004) and 






This study on the clinical profile and outcome of patients with 
obstructive uropathy treated in a tertiary hospital in Cameroon is the 
first one in our setting. It revealed that ¾ of participants had renal 
impairment at presentation with various symptoms (uremic, anuria 
and overload) and 41% needed emergency dialysis but only half of 
them could benefit from this treatment. Hypertension, diabetes and 
HIV were the main associated comorbidities. Fifteen percent of 
patients had urinary tract infection. The main aetiologies of 
obstruction were urolithiasis, begnin prostatic hypertrophy, cancer 
mainly prostatic and cervical cancer, and congenital malformations. 
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Drainage was done only in 45% of patients. Renal recovery 
occurred was low and almost half of patients were loss of follow up. 
1/5 patients died and mortality was associated with prostatic, and 
cervical malignancies and radiotherapy. Urinary tract obstruction is a 
common clinical problem facing urologist. It may be acute or 
chronic, partial or complete, unilateral or bilateral, can occur at any 
site of the urinary tract and lead to rapid deterioration in renal 
function and irreversible kidney damage if urinary drainage is not 
corrected in a time [7]. In our study 76% of patients had renal 
function impairment at presentation with 41% requiring emergency 
dialysis. These results are consistent with the literature: obstruction 
is a relatively common cause of kidney failure but the rate of severe 
renal insufficient with a need for emergency dialysis in our study 
was higher compared to a similar study by Iman in Sudan where 
40% presented with significant renal impairment and 23% required 
emergency dialysis [4-6]. Certain patient-specific factors especially 
CKD traditional risk factors may increase the risk of kidney function 
deterioration amongst patients with obstruction. In this study, 
associated comorbidities such as hypertension, diabetes and HIV 
and also urinary tract infections were frequent, and this could 
probably contribute to the deterioration of renal function of these 
patients. 
  
Signs of obstructive nephropathy are often non-specific, depending 
on the time interval over which the obstruction occurs, the 
lateralization and the severity of obstruction. Although a decrease in 
urine output is frequently observed, normal or elevated urine output 
does not exclude partial obstruction. In the present study 15% of 
patients had anuria and 33% oliguria. However, urine output was 
normal in almost half of patients. Patients presented with various 
symptoms especially uremic sign, sign of volume over load and loin 
pain. The explanation is the late presentation of patients with 
severe renal function deterioration and also by the aetiology of the 
obstruction that was mainly urolithiasis and cancer in this study. 
These findings are consistent with others studies [6, 8, 11]. 
Urolithiasis was the main begnin aetiology (35%) of obstruction in 
this serie and this rate is very high compared to others studies 
[11, 14]. BPH was the second cause of obstruction in our study. 
BHP is a problem experienced by aging men and is the most 
common benign aetiology of obstruction in men, our result are 
similar to the literature were BHP accounted for 30% of obstruction 
in one serie [15]. Hydronephrosis is a common situation in cases of 
advanced malignancies, and the cause of obstruction may be 
invasion of the ureters by tumor, extrinsic compression by a 
retroperitoneal primary or metastatic neoplasia. Cancer was the 
cause of obstruction in 32% of our participants. This rate is very 
high compare to the study of El Iman in Soudan where cancer 
accounted only for 8% of cases [6]. The difference could be due to 
the fact that our study was done in a tertiary referral hospital where 
patients with malignancy in the region are usually referred late. 
Cervical cancer in women and prostatic cancer in men were the 
leading malignancy in our serie. Due to the proximity of the cervix 
to the bladder neck, obstruction can complicate 30% of cervical 
cancers [16] and despite advances in early detection of prostate 
cancer, 10% of patients presented with locally advanced prostate 
cancer with upper urinary tract obstruction as their main symptoms 
[17]. 
  
Once the diagnosis of obstructive uropathy is made, prompt and 
appropriate intervention is necessary to avoid irreversible renal 
damage. Active surgical intervention and creation of adequate urine 
outflow from the obstructed kidney is the method of choice for 
initial treatment even in case of malignancy irrespective of the 
disease stage [10, 18]. In our study drainage could be done only in 
45% of participants and this concerned mainly patients without 
malignancy. Some reasons for this low rate of drainage procedure 
could be the financial constraint in a setting where health insurance 
is almost inexistent with a high rate of patients who were lost to 
follow up after the first consultation, the lack of appropriate material 
and especially the late stage at presentation of patients with 
malignancy. Even if others studies have shown that bypassing the 
obstruction in case of malignancy is a successful way to prolong life, 
most of our patients did not benefit from it [19, 20]. The degree of 
renal recovery depends first on the extent and duration of the 
obstruction together with the presence or absence of infection [11]. 
Total renal recovery occurred in 28% of cases in this study and was 
partial in 4%. Renal outcome was undetermined in almost half of 
the participants who were lost to follow up. The number of patients 
who were lost to follow up is very high in this study and mainly due 
to financial constraint and the ignorance of the consequences of the 
disease. The mortality rate of 22% was associated to cervical and 
prostatic cancer, and radiotherapy. Based on our observations, 
patients with bilateral obstruction secondary to malignant cancer 
should be counselled that their prognosis is poor. These results are 
consistent with other reports in which a malignant cause of 
obstructive uropathy is considered as a prognostic indicator of 
morbidity and reduced survival [14, 21- 23]. 
  
Limitations: this study has some limitations. The retrospective 
data collection from hospital files may induce some inaccuracies and 
missing data. Also it was a single centre study so the findings may 
not be generalized. However, this study is the first to describe the 
profile and outcomes of patients with obstructive uropathy in our 
setting with a heterogeneous group, in a referral tertiary hospital. It 
therefore provides background data that will contribute to raise 





Patients with obstructive uropathy in our setting presented with 
significant impaired renal function Urinary stones and BPH are the 
common begnin causes while prostatic and cervical cancer account 
for the majority of malignancy. Renal recovery is poor, loss to follow 
up and mortality especially due to cancer is high. Specific strategies 
to target improvements in renal recov¬ery and patient's survival are 
needed in this patient group. 
 
What is known about this topic 
• Obstructive nephropathy, is a relatively common condition 
and the main aetiologies depending on the age of patients 
congenital malformations, calculi and tumor. 
• It can lead to renal failure and it is mostly reversible if 
medical and surgical treatment is done early. 
• Mortality is usually very low. 
 
What this study adds 
• Calculi and malignancies were the mains aetiologies. 
• Patients presented late, with renal failure in 76% of cases 
and need for emergency dialysis. 
• Complete renal recovery occurred in 28% of case and 
41% of patients were lost of follow up and 22% died 
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Mean age (years±SD) 50±18 50,7±20 48,6±14 0.43 
Hypertension 39(17) 30(19) 9(13) 0.24 
Diabetes Mellitus 13(6) 11(7) 2(3) 0.21 
Gout 4(2) 4(3) (0) 0.17 
Asthenia 128(57) 85(54) 43(61) 0.30 
Anorexia 124(55) 82(53) 42(60) 0.29 
Hiccup 28(12) 18(12) 10(14) 0.56 
Vomiting 64(28) 37(24) 27(39) 0.02 
Insomnia 39(17) 25(16) 14(20) 0.40 
Cramps 30(13) 20(13) 10(14) 0.70 
Lower limb Oedema 46(20) 25(16) 21(30) 0.01 
Dyspnea 23(10) 13(8) 10(14) 0.10 
Dysuria 33(15) 25(16) 8(11) 0.50 
Abdominal pain 84(37) 54(35) 30(43) 0.78 
  Fever 18(8) 10 (6) 8(11) 0.10 
Macroscopichematuria 15(7) 9(6) 6(6) 0.43 
Urinary tract infection 33(15) 25(16) 8(11) 0.50 
Anuria 33(15) 15(10) 18(26) 0.001 




Table 2: biological parameters and  etiologies of  obstructive uropathy 
 Variables Total Male(%) Female(%) P 
Mean Heamoglobin (SD) 8.40 (±2.4) 8.5 (±2.2) 8.1 (±2.8) 0.31 
Mean Urea (SD) 1.27(±1.07) 1.25 (±1.07) 1.31 (±1.07) 0.71 
Mean Creatinine (SD) 79.34 (±86) 75.9 (±89) 84.6 (±82) 0.56 
Mean GFR(SD) 10.3(±10.3) 11.6 (±10) 7.7 (±10) 0.06 
Impaired renal fonction 172(76) 121(77.5) 51(73) 0.44 
Bladder Cancer 10(4) 7(5) 3(4) 0.70 
Congenital malformations 12(5) 11(7) 1(1) 0.08 




Table 3: treatment  and outcome of patients with obstructive uropathy 
Variables Total Male(%) Female(%) P 
Urethral catherization 44(19.6) 28(24) 6(9) 0.005 
Double JJ 43(19) 27(17) 16(23) 0.32 
Suprapubic catherization 14(6) 12(8) 2(3) 0.16 
Nephrostomy 1(0.4) 0(0) 1(1.4) 0.13 
 Indication for Dialysis 94(41) 62(40) 32(46) 0.20 
Dialysis done 41(18) 31(20) 10(14) 0.12 
Chemotherapy 20 (9) 3(2) 17(24) 0.07 
Radiotherapy 12 (5) 3(2) 9(13) 0.007 
Hormonotherapy 18(8) 18(12) 0(0) 0.003 
 Alpha blockers 21(9) 21(13) 0(0) 0.001 
Analgesic 86(39) 58(37) 28(40) 0.094 
Total renal recovery 63(28) 49(31) 14(20) 0.07 
Partial renal recovery 8(4) 7(4) 1(1) 0.10 
No recovery 12(5) 10(6) 2(3) 0.14 
 Lost to  follow up 94(41) 69(44) 29(41) 0.69 
Death 49(22) 25(16) 24(34) 0.002 
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Table 4: factors associated to mortality of patients with obstructive uropathy  
Factors     Univariate analysis Multivariate analysis 
No Death 
(N=177) 
Death(N=49) OR (95% CI) P OR (95% CI) P 
Age ≥ 50 ans 93 33 2.6(0.8-8.2) 0.09 1.1(0.25-4) 0.89 
Female 46 24 2.7(1.4-5.3) 0.003 1.25(0.17-9) 0.8 
Male 131 25 0.36 (0.1-0.7) 0.001    
Fever 11 7 2.5(0.9-6.8) 0.07    
Uremic syndrome 53 39 9.1 (4.2-19.6) 0.000 1.3(0.5-8) 0.26 
Fluid overload 18 20 6.1 (2.8-12.8) 0.000 1.3(0.4-3) 0.5 
Anuria 15 18 6.2(2.9-13.7) 0.000 2.2(0.6-7) 0.18 
Urinary tract infection 31 2 0.75(0.1-4.1) 0.7    
prostatic cancer 12 14 23.3(5.7-93.9) 0.000 25(4-149) 0.000 
Cervical Cancer 14 21 8.7 (3.7-19.1) 0.000 1.7(2-8.5) 0.004 
Absence of Dialysis 147 38 1.4(0.6-3) 0.3 0.3(0.8-1.1) 0.07 
Radiotherapy 2 10 22.4 (4.7106.4) 0.000 10(1.7-97) 0.03 
  Chemotherapy 8 12 6.8 (2.6-17.9) 0.000 1.2 (0.2-5) 0.8 
  
 
 
 
 
